Q-omics provides the consensus-scored RNU6-502P profile across patient tissues and cancer cell-line models. RNU6-502P expression is associated with patient survival in 14 of 34 cancer types, with the highest sampling consensus in LUSC. Additionally, RNU6-502P RNA expression shows 5,252 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight LUSC, and STAD as cancer lineages where RNU6-502P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for RNU6-502P — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes RNU6-502P survival associations across molecular data types. RNU6-502P RNA expression shows survival associations in the most cancer types (14). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

RNU6-502P data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	14	LUSC (102)	view →

This table ranks reproducible RNU6-502P RNA expression–survival associations across cancer types. High RNU6-502P expression shows unfavorable associations in LUSC, CESC, KICH, SKCM, UCEC and LUAD. The LUSC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .004). Together, the overview and detailed table identify LUSC as the clearest survival context for RNU6-502P RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	DFS	Tertile	III,IV	0.224	0.668	.004	102	view →
CESC	OS	Tertile	III,IV	0.187	0.764	<.001	54	view →
KICH	OS	Tertile	All	0.082	0.877	<.001	54	view →
SKCM	OS	Tertile	III,IV	0.255	0.840	<.001	36	view →
UCEC	DFS	Tertile	II,III,IV	0.099	0.514	.028	30	view →
LUAD	OS	Tertile	III,IV	0.223	0.677	.006	27	view →

Pink = unfavorable, green = favorable. all 14 lineages →

RNU6-502P-LUSC (DFS)

Kaplan–Meier survival curve for RNU6-502P RNA expression in LUSC: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with RNU6-502P in patient tissues and cancer cell lines. In patient samples, RNU6-502P shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	5,252	STAD (4604)	view →
Protein (mass-spec)	3,185	GBM (804)	view →